Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Daiichi Sankyo
Chubb
Cerilliant
Boehringer Ingelheim
McKesson
Mallinckrodt
Farmers Insurance
Deloitte

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071714

« Back to Dashboard

NDA 071714 describes OXAZEPAM, which is a drug marketed by Actavis Elizabeth, Am Therap, Anda Repository, Ivax Sub Teva Pharms, Mylan, Sandoz, Watson Labs, Watson Labs Teva, Parke Davis, and Sun Pharm Industries, and is included in twenty NDAs. It is available from seven suppliers. Additional details are available on the OXAZEPAM profile page.

The generic ingredient in OXAZEPAM is oxazepam. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the oxazepam profile page.
Summary for 071714
Tradename:OXAZEPAM
Applicant:Mylan
Ingredient:oxazepam
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 071714

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength15MG
Approval Date:Oct 20, 1987TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Covington
Cipla
Johnson and Johnson
McKesson
AstraZeneca
Teva
Cantor Fitzgerald
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.